4th Quarter - Report

OGR for AMGEN USA INC

Period 4th Quarter 2009 Filed Jan 19, 2010 Signed by Amy Allman, Chief Administrative Officer

Official filing
Firm
OGR
Client
AMGEN USA INC
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to international tax reform.

LobbyistCovered position, as disclosed
DEAN AGUILLEN Advr, Pelosi; Dir Intgvt Aff, Labor; LA, Sandlin

Contacted: HOUSE OF REPRESENTATIVES

Health Issues HCR

H.R.3962, America's Affordable Health Choices Act of 2009. H.R.1548, Pathway for Biosimilars Act, FDA related issues. H.R.3590, Patient Protection and Affordable Care Act, healthcare issues.

LobbyistCovered position, as disclosed
DEAN AGUILLEN Advr, Pelosi; Dir Intgvt Aff, Labor; LA, Sandlin

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (111th), H.R. 3962 (111th), H.R. 3590 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.